For Research Purposes Only

metabolic

MOTS-c for Insulin Resistance

Preclinical with strong mechanistic data

How It Works

Mitochondrial peptide that activates AMPK and improves glucose uptake.

Research Evidence

Strong preclinical data showing "exercise mimetic" effects. Limited human studies.

Dosing Protocol

5-10mg 2-3x weekly subcutaneously.

Important Considerations

  • !Very limited human data
  • !Expensive
  • !Early research
  • !Consult healthcare provider before use
  • !Quality sourcing is critical

Frequently Asked Questions

Does MOTS-c work for insulin resistance?

Strong preclinical data showing "exercise mimetic" effects. Limited human studies. Research level: Preclinical with strong mechanistic data.

How does MOTS-c help with insulin resistance?

Mitochondrial peptide that activates AMPK and improves glucose uptake.

What is the MOTS-c dosage for insulin resistance?

5-10mg 2-3x weekly subcutaneously.

Is MOTS-c safe for insulin resistance?

Key considerations: Very limited human data. Expensive. Early research. Consult healthcare provider before use. Quality sourcing is critical. Always consult a healthcare provider.

How long until MOTS-c works for insulin resistance?

Results vary by individual and condition severity. Most users report initial effects within 2-4 weeks, with full benefits developing over 8-12 weeks of consistent use.

Learn More

Disclaimer: This information is for educational and research purposes only. MOTS-c is not FDA approved for this use. Consult qualified healthcare professionals.